Andrew Bindman, M.D.
Andrew Bindman, MD, is executive vice president and chief medical officer for Kaiser Foundation Health Plan, Inc. and Hospitals.
In this role, Dr. Bindman is responsible for driving superior quality and equitable health outcomes through the integration of quality innovation, care delivery, and research. Dr. Bindman reports directly to Kaiser Permanente’s chair and chief executive officer and is a member of the National Executive Team.
He works closely with clinical and operational leaders to establish common performance standards for quality and service, drive consistent adoption of key quality programs, and leverage data analytics and research across the enterprise. His areas of focus include advancing the quality outcomes that matter most to members and establishing equity, alongside quality and safety, as a fundamental metric for care.
Dr. Bindman previously spent more than 30 years at the University of California, San Francisco where he practiced and taught clinical medicine while conducting research in health access and outcomes that resulted in more than 190 published scientific articles. A noted health care policy expert, he was an RWJ-HPF on the U.S. House Energy and Commerce Committee during the passage of the Affordable Care Act (ACA). He subsequently had roles within the U.S. Department of Health and Human Services including as Director of the Agency for Healthcare Research and Quality (AHRQ).
Dr. Bindman is a graduate of Harvard College and the Mount Sinai School of Medicine. A board-certified general internist, he completed his residency in internal medicine at UCSF and was a Robert Wood Johnson Foundation Clinical Scholar at Stanford University. He was elected to the National Academy of Medicine in 2015, where he currently serves on the organization’s board for health care services and chairs the workshops on diagnostic excellence.